IndraLab

Statements


Lycorine inhibits JUN. 1 / 1
| 1

reach
"Treatment with lycorine significantly decreases p-FAK, p-Src, p-c-Jun, p-JNK and MMP2 in breast cancer cell lines, demonstrating the effect of lycorine in blocking matrix degradation through the Src/FAK signaling pathway to inhibit migration and invasion."